Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.
2.

MHC class I and II expression in juvenile dermatomyositis skeletal muscle.

Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Sachetti S, Lotufo S, Matsumura N, Marie SK.

Clin Exp Rheumatol. 2009 May-Jun;27(3):519-26.

PMID:
19604449
3.
4.

Class I MHC detection as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM).

Civatte M, Schleinitz N, Krammer P, Fernandez C, Guis S, Veit V, Pouget J, Harlé JR, Pellissier JF, Figarella-Branger D.

Neuropathol Appl Neurobiol. 2003 Dec;29(6):546-52.

PMID:
14636161
6.

MHC Class I overexpression on muscles in early juvenile dermatomyositis.

Li CK, Varsani H, Holton JL, Gao B, Woo P, Wedderburn LR; Juvenile Dermatomyositis Research Group (UK and Ireland).

J Rheumatol. 2004 Mar;31(3):605-9.

PMID:
14994413
7.

Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.

Das L, Blumbergs PC, Manavis J, Limaye VS.

Appl Immunohistochem Mol Morphol. 2013 Dec;21(6):539-42. doi: 10.1097/PAI.0b013e31827d7f16.

PMID:
23343957
8.

Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.

Dorph C, Englund P, Nennesmo I, Lundberg IE.

Ann Rheum Dis. 2006 Dec;65(12):1565-71. Epub 2006 Jul 10.

9.
10.
11.

What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?

Wargula JC, Lovell DJ, Passo MH, Bove KE, Santangelo JD, Levinson JE.

Clin Exp Rheumatol. 2006 May-Jun;24(3):333-43.

PMID:
16870106
12.

Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis.

Sallum AM, Marie SK, Wakamatsu A, Sachetti S, Vianna MA, Silva CA, Kiss MH.

J Rheumatol. 2004 Apr;31(4):801-7.

PMID:
15088312
14.

Muscle involvement in juvenile idiopathic arthritis.

Lindehammar H, Lindvall B.

Rheumatology (Oxford). 2004 Dec;43(12):1546-54. Epub 2004 Sep 1.

15.

Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis.

Gallardo E, de Andrés I, Illa I.

J Neuropathol Exp Neurol. 2001 Sep;60(9):847-55.

16.

Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology.

Alhatou MI, Sladky JT, Bagasra O, Glass JD.

J Mol Histol. 2004 Aug;35(6):615-9.

PMID:
15614615
17.

Expression of HLA class I antigens in skeletal muscle is a diagnostic marker in juvenile dermatomyositis.

Topaloglu H, Muntoni F, Dubowitz V, Sewry C.

J Child Neurol. 1997 Jan;12(1):60-3.

PMID:
9010797
18.

Methylation alterations of WT1 and homeobox genes in inflamed muscle biopsy samples from patients with untreated juvenile dermatomyositis suggest self-renewal capacity.

Wang M, Xie H, Shrestha S, Sredni S, Morgan GA, Pachman LM.

Arthritis Rheum. 2012 Oct;64(10):3478-85. doi: 10.1002/art.34573.

19.

Failure to over express MHC-CLASS-1 on muscle biopsy in a case of amyopathic juvenile dermatomyositis.

McCann LJ, Li CK, Varsani H, Wedderburn LR, Pilkington CA.

Clin Exp Rheumatol. 2007 Jan-Feb;25(1):96-8.

PMID:
17417998
20.

Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.

Gitiaux C, De Antonio M, Aouizerate J, Gherardi RK, Guilbert T, Barnerias C, Bodemer C, Brochard-Payet K, Quartier P, Musset L, Chazaud B, Desguerre I, Bader-Meunier B.

Rheumatology (Oxford). 2016 Mar;55(3):470-9. doi: 10.1093/rheumatology/kev359. Epub 2015 Sep 30.

Items per page

Supplemental Content

Write to the Help Desk